Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

20,328 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
5-Azacitidine has limited therapeutic activity in myelofibrosis.
Mesa RA, Verstovsek S, Rivera C, Pardanani A, Hussein K, Lasho T, Wu W, Tefferi A. Mesa RA, et al. Among authors: wu w. Leukemia. 2009 Jan;23(1):180-2. doi: 10.1038/leu.2008.136. Epub 2008 May 29. Leukemia. 2009. PMID: 18509350 Clinical Trial. No abstract available.
Bortezomib therapy in myelofibrosis: a phase II clinical trial.
Mesa RA, Verstovsek S, Rivera C, Pardanani A, Hussein K, Lasho T, Wu W, Tefferi A. Mesa RA, et al. Among authors: wu w. Leukemia. 2008 Aug;22(8):1636-8. doi: 10.1038/leu.2008.32. Epub 2008 Feb 28. Leukemia. 2008. PMID: 18305559 Free PMC article. Clinical Trial. No abstract available.
Impaired mobilization of hematopoietic stem/progenitor cells in C5-deficient mice supports the pivotal involvement of innate immunity in this process and reveals novel promobilization effects of granulocytes.
Lee HM, Wu W, Wysoczynski M, Liu R, Zuba-Surma EK, Kucia M, Ratajczak J, Ratajczak MZ. Lee HM, et al. Among authors: wu w. Leukemia. 2009 Nov;23(11):2052-62. doi: 10.1038/leu.2009.158. Epub 2009 Aug 6. Leukemia. 2009. PMID: 19657368 Free PMC article.
20,328 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page